The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
A consumer-level, nationwide recall has been issued for several over-the-counter eye care products after serious manufacturing violations were revealed in a U.S. Food and Drug Administration audit.
Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results